3-Acetyl-N-(5-iodopyridin-2-yl)-5-methyl-1,2-oxazole-4-carboxamide

Catalog No. :
ACFLAF709
CAS No. :
339018-07-4
Molecular Formula :
C12H10IN3O3
Molecular Weight :
371.13

IUPAC Name:3-acetyl-N-(5-iodopyridin-2-yl)-5-methylisoxazole-4-carboxamide

3-Acetyl-N-(5-iodopyridin-2-yl)-5-methyl-1,2-oxazole-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Acetyl-N-(5-iodopyridin-2-yl)-5-methyl-1,2-oxazole-4-carboxamide
IUPAC Name3-acetyl-N-(5-iodopyridin-2-yl)-5-methylisoxazole-4-carboxamide
MDL No.MFCD01315244
Molecular FormulaC12H10IN3O3
Molecular Weight371.13
SMILESO=C(C1=C(C)ON=C1C(C)=O)NC2=NC=C(I)C=C2
InChI KeySYKOPIBYUPRMHK-UHFFFAOYSA-N
Synonym3-ACETYL-N-(5-IODO-2-PYRIDINYL)-5-METHYL-4-ISOXAZOLECARBOXAMIDE;3-acetyl-N-(5-iodopyridin-2-yl)-5-methyl-1,2-oxazole-4-carboxamide;4-Isoxazolecarboxamide, 3-acetyl-N-(5-iodo-2-pyridinyl)-5-methyl-
CAS No.339018-07-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFLAF709 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFOMR719 route compound structure diagram
    ACFOMR71920511-12-0 In Stock
  4. Then
  5. ACFLAF709 route product structure diagram
    ACFLAF709339018-07-4
Inquiry

2. ACFLAF709 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFOMR719 route compound structure diagram
    ACFOMR71920511-12-0 In Stock
  4. Then
  5. ACFLAF709 route product structure diagram
    ACFLAF709339018-07-4
Inquiry

Comments (0)